PharmaShots | Incisive News in 3 Shots

Subscribe Now

Expanded Label Approval

Eli Lilly's Lyumjev (insulin lispro-aabc injection) Receives the US FDA's Expanded Label Approval for the Treatment of Type 1 and Type 2 Diabetes

Eli Lilly's Lyumjev (insulin lispro-aabc injection) Receives the US FDA's Expanded Label Approval for the Treatment of Type 1 and...

August 17, 2021

AstraZeneca's Farxiga and Xigduo XR Receives FDA's Expanded Label Approval for Type 2 Diabetes (T2D) and Moderate Renal Impairment

AstraZeneca's Farxiga and Xigduo XR Receives FDA's Expanded Label Approval for Type 2 Diabetes (T2D) and Moderate Renal Impairment

February 28, 2019

Merck's Gardasil 9 Receives FDA's Expanded Label Approval for Prevention of HPV Related Disorders

Merck's Gardasil 9 Receives FDA's Expanded Label Approval for Prevention of HPV Related Disorders

October 8, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us